Prof.Dr. Arnold G. Vulto, Ziekenhuisapotheker en Farmacoloog, ErasmusMC Rotterdam;
Voorzitter Stichting Initiatiefgroep Biosimilars Nederland
Professor Vulto is the (co)author of more than 150 international peer-reviewed papers and has been supervising more than 20 PhD projects. He was a member of the Board of Directors of the European Association of Hospital Pharmacists (EAHP) and was Chairman of its Scientific Committee. He was a member of the Steering Committee and chair of the Program Committee of the First Global Conference on the Future of Hospital Pharmacy (Basel, 2008).
In 2008 he was one of the founders of the Generics & Biosimilars Initiative (GaBI), followed by the foundation of the Dutch Initiatiefgroep Biosimilars in 2013, from which he became the chairman in 2017. In 2016 he was one of the founders of the MABEL Research Fund at Leuven University, aimed at investigating developments in the biologics market after the loss of market exclusivity. In 2017 he was appointed as Honorary Professor at the KU Leuven.